Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the creation of compounds targeting central nervous system disorders, including antipsychotic and antidepressant drugs. Its trifluoroethyl group enhances the metabolic stability and bioavailability of the resulting molecules, making it a crucial component in drug design. Additionally, it is employed in the development of radiopharmaceuticals for diagnostic imaging, aiding in the study of neurological conditions.